cbdMD, Inc. (YCBD): history, ownership, mission, how it works & makes money

cbdMD, Inc. (YCBD): history, ownership, mission, how it works & makes money

US | Healthcare | Drug Manufacturers - Specialty & Generic | AMEX

cbdMD, Inc. (YCBD) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



A Brief History of cbdMD, Inc. (YCBD)

Company Overview

cbdMD, Inc. (YCBD) is a publicly traded company headquartered in Charlotte, North Carolina, focused on producing and marketing CBD products.

Financial Performance

Fiscal Year Total Revenue Net Income/Loss
2023 $33.3 million ($14.2 million)
2022 $50.1 million ($22.7 million)

Product Portfolio

  • CBD Oils
  • CBD Gummies
  • CBD Topicals
  • CBD Capsules
  • CBD Pet Products

Stock Performance

As of January 2024, YCBD trades on the NYSE American exchange with a market capitalization of approximately $30.5 million.

Key Operational Metrics

Metric 2023 Value
Gross Margin 42.1%
Operating Expenses $20.1 million

Corporate Structure

Executive Leadership: Martin A. Sumichrast serves as Chairman and CEO.

Market Position

cbdMD operates in the competitive CBD wellness product market, targeting direct-to-consumer and retail distribution channels.



A Who Owns cbdMD, Inc. (YCBD)

Major Shareholders

As of the most recent SEC filings, the top institutional shareholders of cbdMD, Inc. include:

Institutional Investor Shares Owned Percentage of Ownership
Renaissance Technologies LLC 521,716 shares 3.24%
Vanguard Group Inc 446,814 shares 2.78%
Morgan Stanley 279,648 shares 1.74%

Insider Ownership

Key insider ownership details:

  • CEO Martin A. Sumichrast owns 1,350,000 shares
  • Director Michael Moe owns 275,000 shares
  • Total insider ownership represents approximately 8.9% of total outstanding shares

Ownership Structure

Publicly traded company details:

  • Total Outstanding Shares: 16,076,000
  • Ticker Symbol: YCBD
  • Listed on: NYSE American


cbdMD, Inc. (YCBD) Mission Statement

Company Overview

cbdMD, Inc. (NASDAQ: YCBD) is a publicly traded cannabidiol (CBD) company headquartered in Charlotte, North Carolina.

Financial Performance

Financial Metric 2023 Value
Annual Revenue $25.4 million
Net Loss ($15.6 million)
Total Assets $37.2 million

Mission Statement Components

  • Provide high-quality CBD products
  • Promote wellness through natural solutions
  • Ensure product transparency and third-party testing

Product Portfolio

Product Category Number of Products
Tinctures 12
Topicals 8
Gummies 6

Market Position

Market Share in CBD Segment: Approximately 3.5% of the total CBD market

Operational Metrics

  • Manufacturing Locations: 2
  • Distribution Channels: Online, Retail, Wholesale
  • Countries Served: United States, Canada


How cbdMD, Inc. (YCBD) Works

Company Overview

cbdMD, Inc. (NYSE American: YCBD) is a publicly traded cannabidiol (CBD) company headquartered in Charlotte, North Carolina.

Financial Performance

Financial Metric 2023 Value
Total Revenue $27.4 million
Net Loss $14.1 million
Cash and Cash Equivalents $5.2 million

Product Portfolio

  • CBD Tinctures
  • CBD Topicals
  • CBD Gummies
  • CBD Capsules
  • CBD Pet Products

Distribution Channels

Retail Channels:

  • Online Direct-to-Consumer
  • Retail Stores
  • E-commerce Platforms

Market Position

Market capitalization as of January 2024: $14.6 million

Operational Strategy

Focuses on creating high-quality, third-party tested CBD products across multiple consumer segments.



How cbdMD, Inc. (YCBD) Makes Money

Revenue Streams

cbdMD, Inc. generates revenue through the following primary channels:

  • Direct-to-consumer online sales
  • Wholesale distribution to retailers
  • CBD product line sales

Product Portfolio

Product Category Revenue Contribution
CBD Oils 42.3%
CBD Topicals 22.7%
CBD Gummies 18.5%
CBD Capsules 12.5%
Other CBD Products 4%

Financial Performance

Annual Revenue (2023): $27.4 million

Gross Margin: 55.6%

Operating Expenses: $18.6 million

Sales Channels

Sales Channel Percentage
E-commerce 65.2%
Retail Partnerships 28.3%
Wholesale 6.5%

Market Segments

  • Wellness consumers
  • Pain management
  • Sleep aid
  • Stress relief

Geographic Distribution

Region Sales Percentage
United States 92.7%
International Markets 7.3%

DCF model

cbdMD, Inc. (YCBD) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.